Ridge augmentation done for bone defects using a combination of platelet concentrate and graft material.
- Conditions
- Health Condition 1: K063- Horizontal alveolar bone loss
- Registration Number
- CTRI/2020/06/025567
- Lead Sponsor
- Jane BelindaT
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients who are between 18-60 years of age.
2.All sites had to be healed sites, that is at least 6 months of post extraction healing was required.
3.Each site bordered by at least one tooth.
4.Single edentulous sites were the treatment planned to receive a dental implant that was evaluated to have inadequate horizontal dimensions for implant placement and classified as either Seibert Class I or III.
1.Debilitating systemic diseases or diseases that have a clinically significant effect on wound healing.
2.History of intravenous bisphosphonate use or oral bisphosphonate use for >3 years
3.Smokers.
4.Pregnancy or lactation
5.Known allergy to any material or medication used in the study.
6.Any Previous History of head and neck radiation therapy
7.Chemotherapy in the last 12 months
8.Severe psychologic problems
9.Failed to sign an informed consent approved by the Human Studies Committee.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary clinical outcome variable is evaluated based on the crestal horizontal ridge width.Timepoint: 1.baseline <br/ ><br>2.6 months
- Secondary Outcome Measures
Name Time Method 1.Changes in Vertical Bone Height Dimension <br/ ><br>2.Comparison of Horizontal ridge width dimensions between Group I and Group II, <br/ ><br>3.Changes in Vertical Height Dimensions between the Group I and Group II <br/ ><br>4.Changes in Vestibular Depth <br/ ><br>5.Changes in width of keratinized tissue within groups and between groupsTimepoint: 1.baseline <br/ ><br>2.6 months